HIV coinfection with hepatitis b: Difference between revisions
No edit summary |
|||
Line 8: | Line 8: | ||
In areas of low endemicity, such as North America, Australia and Europe, HBV and HIV infection are usually acquired in adulthood through sexual or percutaneous transmission. In areas of low endemicity, the prevalence of chronic co infection is around 5-7% among HIV-infected individuals. | In areas of low endemicity, such as North America, Australia and Europe, HBV and HIV infection are usually acquired in adulthood through sexual or percutaneous transmission. In areas of low endemicity, the prevalence of chronic co infection is around 5-7% among HIV-infected individuals. | ||
[[Category:Hepatitis|B]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Infectious disease]] | |||
[[Category:Disease]] |
Revision as of 15:28, 29 March 2012
Hepatitis B |
Diagnosis |
Treatment |
Case Studies |
HIV coinfection with hepatitis b On the Web |
American Roentgen Ray Society Images of HIV coinfection with hepatitis b |
Risk calculators and risk factors for HIV coinfection with hepatitis b |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Co infection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) is common due to shared routes of transmission.
Epidemiology
In areas of low endemicity, such as North America, Australia and Europe, HBV and HIV infection are usually acquired in adulthood through sexual or percutaneous transmission. In areas of low endemicity, the prevalence of chronic co infection is around 5-7% among HIV-infected individuals.